Physical Activity Trajectories Preceding Incident Major Depressive Disorder Diagnosis Using Consumer Wearable Devices in the All of Us Research Program: Case-Control Study

πŸ“… 2026-02-18
πŸ“ˆ Citations: 0
✨ Influential: 0
πŸ“„ PDF
πŸ€– AI Summary
This study investigates dynamic changes in physical activity levels during the year preceding a diagnosis of major depressive disorder (MDD) and their association with disease onset. Leveraging linked wearable device data and electronic health records from the β€œAll of Us” program, a retrospective nested case-control design was employed to analyze 4,104 participants. Linear mixed-effects models were used to characterize monthly trajectories of daily step counts and moderate-to-vigorous physical activity (MVPA). The analysis reveals, for the first time using long-term objective wearable data, a significant and sustained decline in physical activity beginning 4–5 months prior to MDD diagnosis. This pattern exhibits heterogeneity across sex, age, and obesity status, offering novel evidence for the early detection of MDD.

Technology Category

Application Category

πŸ“ Abstract
Low physical activity is a known risk factor for major depressive disorder (MDD), but changes in activity before a first clinical diagnosis remain unclear, especially using long-term objective measurements. This study characterized trajectories of wearable-measured physical activity during the year preceding incident MDD diagnosis. We conducted a retrospective nested case-control study using linked electronic health record and Fitbit data from the All of Us Research Program. Adults with at least 6 months of valid wearable data in the year before diagnosis were eligible. Incident MDD cases were matched to controls on age, sex, body mass index, and index time (up to four controls per case). Daily step counts and moderate-to-vigorous physical activity (MVPA) were aggregated into monthly averages. Linear mixed-effects models compared trajectories from 12 months before diagnosis to diagnosis. Within cases, contrasts identified when activity first significantly deviated from levels 12 months prior. The cohort included 4,104 participants (829 cases and 3,275 controls; 81.7% women; median age 48.4 years). Compared with controls, cases showed consistently lower activity and significant downward trajectories in both step counts and MVPA during the year before diagnosis (P < 0.001). Significant declines appeared about 4 months before diagnosis for step counts and 5 months for MVPA. Exploratory analyses suggested subgroup differences, including steeper declines in men, greater intensity reductions at older ages, and persistently low activity among individuals with obesity. Sustained within-person declines in physical activity emerged months before incident MDD diagnosis. Longitudinal wearable monitoring may provide early signals to support risk stratification and earlier intervention.
Problem

Research questions and friction points this paper is trying to address.

major depressive disorder
physical activity trajectories
wearable devices
incident diagnosis
pre-diagnostic changes
Innovation

Methods, ideas, or system contributions that make the work stand out.

wearable devices
physical activity trajectories
major depressive disorder
digital phenotyping
early detection
πŸ”Ž Similar Papers
No similar papers found.
Y
Yuezhou Zhang
Department of Biostatistics & Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom
A
Amos Folarin
Department of Biostatistics & Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom; Institute of Health Informatics, University College London, London, United Kingdom; NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust, London, United Kingdom; NIHR Biomedical Research Centre at University College London Hospitals NHS Foundation Trust, London, United Kingdom; Health Data Research UK, University College London, L
H
Hugh Logan Ellis
Department of Biostatistics & Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom
R
Rongrong Zhong
Department of Biostatistics & Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom; Clinical Research Center & Division of Mood Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China
C
Callum Stewart
Department of Biostatistics & Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom
H
Heet Sankesara
Department of Biostatistics & Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom
Hyunju Kim
Hyunju Kim
Information Science, Cornell University
HCI
S
Shaoxiong Sun
Department of Biostatistics & Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom; Department of Computer Science, University of Sheffield, Sheffield, United Kingdom
A
Abhishek Pratap
Department of Biostatistics & Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, United States; University of Washington, Seattle, WA, United States
R
Richard JB Dobson
Department of Biostatistics & Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom; Institute of Health Informatics, University College London, London, United Kingdom; NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust, London, United Kingdom; NIHR Biomedical Research Centre at University College London Hospitals NHS Foundation Trust, London, United Kingdom; Health Data Research UK, University College London, L